Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis

JACC Heart Failure(2020)10.1016/j.jchf.2020.04.007Source: DataRank Database

Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 0. It has been cited 289 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access289 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 11.11)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Lisa R. Yanek ORCID,Joban Vaishnav ORCID,Wendy Ying ORCID,Dhananjay Vaidya ORCID,Yizhen J. Lee

Live enrichment

PubMed:32653448 PMC:PMC7604801 OpenAlex:https://openalex.org/W3041983337

American Heart Association

Grant: 16SFRN28780016

National Institutes of Health

Grant: 2T32HL007227-44

NHLBI NIH HHS

Grant: R35 HL135827

NHLBI NIH HHS

Grant: T32 HL007227

Perelman School of Medicine, University of Pennsylvania

National Heart, Lung, and Blood Institute

Johns Hopkins University

FWCI

11.11

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7604801

publisherhttps://api.elsevier.com/content/article/PII:S2213177920302535?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213177920302535?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jchf.2020.04.007

Fields of Study

Amyloidosis: Diagnosis, Treatment, OutcomesCardiovascular Function and Risk FactorsCardiac Imaging and DiagnosticsAgedAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsBiopsyCardiac CatheterizationFemaleHeart FailureHeart TransplantationHumansMyocardiumPrevalenceProspective StudiesStroke VolumeTissue Donors

MeSH Terms

AgedAngiotensin-Converting Enzyme InhibitorsBiopsyFemaleCardiac CatheterizationHeart FailureHumansMyocardiumProspective StudiesStroke VolumeTissue DonorsPrevalenceHeart TransplantationAngiotensin Receptor Antagonists

Keywords

MedicineCardiac amyloidosisCardiologyHeart failureInternal medicineHeart failure with preserved ejection fractionEjection fractionAmyloidosisLeft ventricular hypertrophyBlood pressureInflammationhypertrophyBiopsyfibrosisHfpef

Sustainable Development Goals

SDG 0: Good health and well-being